Entheon Biomedical Corp. (ENBI.CN)

CAD 0.17

(0.0%)

Annual Income Statements

(In CAD)
Breakdown 2023 2022 2021 2020 2019 2019
Revenue 250.32 Thousand 189.67 Thousand 21.67 Thousand - - -
Cost of Revenue - 2095.00 12.54 Thousand 2724.00 - -
Gross Profit 250.32 Thousand 187.58 Thousand 9130.00 -2724.00 - -
Operating Expenses 564.31 Thousand 3.79 Million 9.11 Million 4.37 Million 667.26 Thousand 170.01 Thousand
Selling, General and Administrative Expenses 564.31 Thousand 2.58 Million 7.13 Million 3.93 Million 528.84 Thousand 169.52 Thousand
Research and Development Expenses - 1.19 Million 1.49 Million 442.56 Thousand 129.72 Thousand -
Other Expenses - 2095.00 487.64 Thousand 2724.00 - -30.11 Thousand
Cost and Expenses 564.31 Thousand 3.79 Million 9.12 Million 4.37 Million 667.26 Thousand 170.01 Thousand
Operating Income -313.99 Thousand -3.55 Million -9.31 Million -4.37 Million -658.56 Thousand -170.01 Thousand
Interest Expense - - - - - 218.00
Income Tax Expense - 4.97 Million -216.64 Thousand -3459.00 -8707.00 -72.55 Thousand
Earnings before Tax -300 Thousand -2.06 Million -8.88 Million -4.38 Million -667.26 Thousand -230.08 Thousand
Net Income -300 Thousand -7.03 Million -8.66 Million -4.37 Million -667.26 Thousand -157.53 Thousand
Earnings Per Share Basic -0.05 -0.12 -0.15 -1.60 -0.11 -0.04
Earnings Per Share Diluted -0.05 -0.12 -0.15 -1.60 -0.11 -0.04
Weighted Average Shares Outstanding 5.9 Million 59.08 Million 56.83 Million 2.74 Million 6.03 Million 4.18 Million
Weighted Average Shares Outstanding (Diluted) 5.9 Million 59.08 Million 56.86 Million 2.74 Million 6.03 Million 4.18 Million
Gross Margin 1.00 0.99 0.42 - - -
EBIT Margin 0.06 -18.71 -407.24 - - -
Profit Margin -1.20 -37.07 -400.09 - - -
EBITDA 13.99 Thousand -3.59 Million -8.17 Million -1.63 Million -8707.00 -229.37 Thousand
Earnings Before Tax Margin -1.25 -18.72 -429.74 - - -

Income Statement Charts